TrialCancer immunology, immunotherapy : CII2017
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
Sapna P Patel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it